R Hirschelmann

690 total citations
81 papers, 585 citations indexed

About

R Hirschelmann is a scholar working on Molecular Biology, Pharmacology and Physiology. According to data from OpenAlex, R Hirschelmann has authored 81 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 19 papers in Pharmacology and 13 papers in Physiology. Recurrent topics in R Hirschelmann's work include Inflammatory mediators and NSAID effects (12 papers), Neuropeptides and Animal Physiology (8 papers) and Estrogen and related hormone effects (7 papers). R Hirschelmann is often cited by papers focused on Inflammatory mediators and NSAID effects (12 papers), Neuropeptides and Animal Physiology (8 papers) and Estrogen and related hormone effects (7 papers). R Hirschelmann collaborates with scholars based in Germany, South Korea and United States. R Hirschelmann's co-authors include H Bekemeier, Burkhard Hinz, W. Bürger, Kerstin Krause, Peter Nuhn, R Weidhase, Thomas Köhler, Ana Isabel Martı́n, K. Hiller and Julia Metzner and has published in prestigious journals such as Cellular and Molecular Life Sciences, Biochemical Pharmacology and Life Sciences.

In The Last Decade

R Hirschelmann

77 papers receiving 554 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Hirschelmann Germany 11 189 89 88 87 82 81 585
Christine Heberden France 14 230 1.2× 31 0.3× 147 1.7× 67 0.8× 34 0.4× 24 579
Fiorella Miceli Italy 21 234 1.2× 52 0.6× 136 1.5× 214 2.5× 54 0.7× 33 1.1k
Silvano Sacco Italy 22 263 1.4× 110 1.2× 154 1.8× 62 0.7× 110 1.3× 43 1.1k
V H Auerbach United States 8 263 1.4× 88 1.0× 209 2.4× 139 1.6× 30 0.4× 12 833
Maria Strömstedt Sweden 20 522 2.8× 85 1.0× 145 1.6× 261 3.0× 81 1.0× 32 1.1k
Marı́a Laura Barreiro Arcos Argentina 16 253 1.3× 91 1.0× 96 1.1× 276 3.2× 30 0.4× 37 902
K.-H. Fritzemeier Germany 18 248 1.3× 57 0.6× 37 0.4× 200 2.3× 59 0.7× 25 853
Cui Yang China 19 423 2.2× 83 0.9× 133 1.5× 121 1.4× 116 1.4× 58 930
Ke Cui China 12 251 1.3× 52 0.6× 86 1.0× 26 0.3× 48 0.6× 34 725
Alessio Cremonesi Switzerland 9 376 2.0× 47 0.5× 82 0.9× 61 0.7× 43 0.5× 18 727

Countries citing papers authored by R Hirschelmann

Since Specialization
Citations

This map shows the geographic impact of R Hirschelmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Hirschelmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Hirschelmann more than expected).

Fields of papers citing papers by R Hirschelmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Hirschelmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Hirschelmann. The network helps show where R Hirschelmann may publish in the future.

Co-authorship network of co-authors of R Hirschelmann

This figure shows the co-authorship network connecting the top 25 collaborators of R Hirschelmann. A scholar is included among the top collaborators of R Hirschelmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Hirschelmann. R Hirschelmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kraft, Jeannette, Gerburg Keilhoff, J. Miersch, et al.. (1998). Biological effects of the dihydroorotate dehydrogenase inhibitor polyporic acid, a toxic constituent of the mushroom Hapalopilus rutilans  , in rats and humans. Archives of Toxicology. 72(11). 711–721. 18 indexed citations
2.
Schmidt, Klaus M., et al.. (1993). Megadose glucocorticoid therapy: Investigations in rat anaphylactic shock and experimental allergic encephalomyelitis. Inflammation Research. 38(S2). C108–C111. 2 indexed citations
3.
Hirschelmann, R, et al.. (1991). Steroid-Saving Potency of Nonsteroidal Antiinflammatory Agents — A Reevaluation with the New Agent CGP 28238 in Rat Inflammatory Models. Birkhäuser Basel eBooks. 32. 51–57. 4 indexed citations
4.
Hirschelmann, R, et al.. (1991). GCP 28 238, a new potent nonsteroidal antiinflammatory agent: Its relation to arachidonic acid metabolism. Inflammation Research. 32(1-2). 54–55. 4 indexed citations
5.
Hirschelmann, R, et al.. (1991). Rat heart anaphylaxis: Influence of mediator antagonists. General Pharmacology The Vascular System. 22(4). 673–675. 5 indexed citations
6.
7.
Bekemeier, H, et al.. (1989). Role of EDRF in inflammation-induced vasodepression in the rat leg. Inflammation Research. 26(1-2). 219–221.
8.
Bekemeier, H & R Hirschelmann. (1989). Reactivity of resistance blood vessels ex vivo after administration of toxic chemicals to laboratory animals: arteriolotoxicity. Toxicology Letters. 49(1). 49–54. 5 indexed citations
9.
Hirschelmann, R, Volker Böhm, & T. Funke. (1988). Hydrogen peroxide productionex vivo by peritonitis exudate leukocytes of rats and influence of dexamethasone and a glucocorticoid antagonist. Inflammation Research. 23(1-2). 101–102. 2 indexed citations
10.
Hirschelmann, R, et al.. (1988). Dexamethasone antagonism by RU 38486 in inflammatory reactions of the rat. Part 2: Biochemical parameters: RNA content of inflammation cells and acute phase reactants of the blood.. PubMed. 43(5). 370–1. 5 indexed citations
11.
Bekemeier, H, R Hirschelmann, Uwe Lange, & G Nowak. (1988). Strain-dependence of kappa-carrageenin thrombosis in rats and mice. Inflammation Research. 23(1-2). 108–109. 2 indexed citations
12.
Bürger, W., et al.. (1987). Modulation of rat C-reactive protein serum level by dexamethasone and adrenaline-comparison with the response of α2 phase globulin. Inflammation Research. 22(3-4). 280–287. 9 indexed citations
13.
Hirschelmann, R & H Bekemeier. (1987). Thrombosis (infarction) induced by kappa- carrageenin in rat tail: inhibition during adjuvant arthritis. Experimental Pathology. 31(3). 175–178. 2 indexed citations
14.
Bekemeier, H & R Hirschelmann. (1986). On steroid-saving drug combinations in carrageenin paw edema and adjuvant arthritis.. PubMed. 36(10). 1521–4. 9 indexed citations
15.
Hirschelmann, R & H Bekemeier. (1986). Influence of the Iron Chelating Agent Desferrioxamine on two Rat Inflammatory Models. Free Radical Research Communications. 2(1-2). 125–127. 4 indexed citations
16.
Bekemeier, H, et al.. (1984). Carrageenin-induced thrombosis in the rat and mouse as a test model of substances influencing thrombosis.. PubMed. 43(8-9). S347–50. 17 indexed citations
17.
Hirschelmann, R & H Bekemeier. (1984). Problems and results in testing the possible mode of anti-inflammatory glucocorticoid action in carrageenin rat paw oedema: advantages of local substance injection.. PubMed. 6(6). 471–5. 5 indexed citations
18.
Bekemeier, H, et al.. (1982). Blood vessel reactivity on noradrenaline, vasopressin, and prostaglandin F2 alpha, resp., in the isolated perfused hind legs of rats with edemas or adjuvant arthritis.. PubMed. 10. 135–46. 1 indexed citations
19.
Hirschelmann, R, et al.. (1975). [Modification of the adjuvans arthritis by carrageenin, compound 48/80, histamine- and serotonin antagonists, non-steroid antiphlogistics as well as protease inhibitors and their possible relations to inflammation mediators].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 34(8). 1397–406. 2 indexed citations
20.
Hirschelmann, R, et al.. (1974). [Effects of compound 48-80, reserpine and carrageenan on 6-sulfanilaminoindazole arthritis].. PubMed. 29(1). 59–60. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine Heberden Breakdown of academic impact, for papers by Fiorella Miceli Breakdown of academic impact, for papers by Silvano Sacco Breakdown of academic impact, for papers by V H Auerbach Breakdown of academic impact, for papers by Maria Strömstedt Breakdown of academic impact, for papers by Marı́a Laura Barreiro Arcos Breakdown of academic impact, for papers by K.-H. Fritzemeier Breakdown of academic impact, for papers by Cui Yang Breakdown of academic impact, for papers by Ke Cui Breakdown of academic impact, for papers by Alessio Cremonesi
Rankless by CCL
2026